Journal Publications

Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.

Author(s) Date Article Title Journalsort descending

Tobias Klatte, Kevin M. Gallagher, Luca Afferi, Alessandro Volpe, Nils Kroeger, Silvia Ribback, Alan McNeill, Antony C. P. Riddick, James N. Armitage, Tevita F. Aho, Tim Eisen, Kate Fife, Axel Bex, Allan J. Pantuck, Grant D. Stewart

 October 2019 The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort BMC Medicine

Omar Abdel-Rahman

 June 2018 Patterns of on-treatment cardiac adverse events within three clinical trials of adjuvant anthracycline-based chemotherapy Breast Cancer

Junjie Hang, Lixia Wu, Lina Zhu, Khigiang Sun, Ge Wang, Jingjing Pan, Suhua Zheng, Kequn Xu, Jiadi Du, Hua Jiang

 June 2018 Prediction of Overall Survival for Metastic Pancreatic Cancer: Development and Validation of a Prognostic Nomogram with Data from Open Clinical Trial and Real-World Study Cancer Medicine

Omar Abdel-Rahman

 December 2018 Impact of Regional Nodal Irradiation on the Outcomes of N1 Breast Cancer Patients Referred for Adjuvant Treatment: A Patient-Level Pooled Analysis of 2 Clinical Trials Clinical Breast Cancer

Timothe Menard, Bjorn Koneswarakantha, Donato Rolo, Yves Barmaz, Leszek Popko, Rich Bowling

 December 2019 Follow‑Up on the Use of Machine Learning in Clinical Quality Assurance: Can We Detect Adverse Event Under‑Reporting in Oncology Trials? Drug Safety

Michael A. Webster-Clark, Hanna K. Sanoff, Til Stürmer, Sharon Peacock Hinton, Jennifer L. Lund

 January 2019 Diagnostic Assessment of Assumptions for External Validity - An Example Using Data in Metastatic Colorectal Cancer Epidemiology

Omar Abdel-Rahman

 July 2018 Predictors of skeletal-related events among cancer patients with bone metastases treated with zoledronic acid: a secondary analysis of a randomized study Expert Opinion on Drug Safety

Anway Giryes, Hani Oweira, Meinrad Mannhart, and Omar Abdel-Rahman

 July 2018 Impact of primary tumor side on the outcomes of patients with non-metastatic colon cancer; a patient-level pooled analysis of two clinical trials Expert Review of Gastroenterology and Hepatology

Hani Oweira, Anway Giryes, Meinrad Mannhart, Michael Decker, and Omar Abdel-Rahman

 August 2018 Impact of Time to Start Systemic Therapy on the Outcomes of Patients with Metastatic Colorectal Cancer Treated with First Line FOLFOX Chemotherapy; a Patient-Level Pooled Analysis of Two Clinical Trials Expert Review of Gastroenterology and Hepatology

Detian Deng, Yu Du, Zhicheng Ji, Karthik Rao, Zhenke Wu, Yuxin Zhu, R. Yates Coley

 November 2017 Predicting survival time for metastatic castration resistant prostate cancer: An iterative imputation approach F1000 Research

Soren Wengel Mogensen, Anne H. Petersen, Ann-Sophie Buchardt, Niels Richard Hansen

 November 2017 Survival prognosis and variable selection: A case study for metastatic castrate resistant prostate cancer patients F1000 Research

Motoki Shiga

 November 2017 Two-step feature selection for predicting survival time of patients with metastatic castrate resistant prostate cancer F1000 Research

Massimiliano Zanin

 November 2017 Using complex networks for refining survival prognosis in prostate cancer patient F1000 Research

Sebastian Pölsterl, Pankaj Gupta, Lichao Wang, Sailesh Conjeti, Amin Katouzian, Nassir Navab

 July 2017 Heterogeneous ensembles for predicting survival of metastatic, castrate-resistant prostate cancer patients F1000 Research

Pages